Generic Name and Formulations:
Lifitegrast 5%; oph soln.
Shire US, Inc.
Indications for XIIDRA:
Signs and symptoms of dry eye disease.
Instill 1 drop twice daily (~12hrs apart) in each eye.
<17yrs: not established.
Remove contact lens prior to use; may reinsert 15mins after administration. Pregnancy. Nursing mothers.
Lymphocyte function-associated antigen-1 (LFA-1) antagonist.
Instillation site irritation, dysgeusia, decreased visual acuity; hypersensitivity.
Single-use containers (0.2mL)—60
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Oxidized Low-Density Lipoprotein May Predict Risk for Recurrent Stroke
- Inappropriate Prescribing Protocols in Parkinson Disease
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Congress Passes Bill to Fight Opioid Crisis